Selective organ preservation in muscle-invasive bladder cancer: Review of the literature

Surgical Oncology

Volumn 21, Issue 1, 2012, Pages

  Khosravi Shahi, Parham ^a   Cabezón Gutiérrez, Luis ^a  

^a HOSPITAL UNIVERSITARIO DE TORREJÓN   (Spain)

Author keywords

Cisplatin; Radical cystectomy; Radiochemotherapy; T2 T3; TURBT

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; VINBLASTINE;

BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; CYSTITIS; ENTERITIS; HEALTH CARE QUALITY; HUMAN; LYMPH NODE DISSECTION; MUSCLE INVASIVE BLADDER CANCER; ORGAN PRESERVATION; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SELECTIVE ORGAN PRESERVATION; TRANSIENT UROCYSTITIS; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TREATMENT RESPONSE; TUMOR VOLUME; UROLOGIST;

ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; CHEMORADIOTHERAPY; CISPLATIN; CLINICAL TRIALS AS TOPIC; HUMANS; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; ORGAN SPARING TREATMENTS; PATIENT SELECTION; QUALITY OF LIFE; SALVAGE THERAPY; TREATMENT OUTCOME; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84855833114     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2011.10.004     Document Type: Review

References (30)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics CA Cancer J Clin 2005 55 2002 74 108
2. J. Ferlay, H.R. Shin, and F. Bray Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 127 2010 2893 2917
3. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
4. J.N. Eble, G. Sauter, J.I. Epstein, and I.A. Sesterhenn World Health Organization classification of tumors. Tumors of the urinary system and genital organs. Pathology and genetics 2004 IARC Press Lyon
5. D.S. Kaufman, W.U. Shipley, P.P. Griffin, N.M. Heney, A.F. Althausen, and J.T. Efird Selective bladder preservation by combination treatment of invasive bladder cancer N Engl J Med 329 1993 1377 1382 (Pubitemid 23317347)
6. W.U. Shipley, D.S. Kaufman, E. Zehr, N.M. Heney, S.C. Lane, and H.K. Thakral Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer Urology 60 2002 62 68
7. C. Rödel, G.G. Grabenbauer, R. Kühn, T. Papadopoulos, J. Dunst, and M. Meyer Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results J Clin Oncol 20 2002 3061 3071 (Pubitemid 34791095)
8. M. Housset, C. Maulard, and Y. Chretien Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study J Clin Oncol 11 1993 2150 2157 (Pubitemid 23332251)
9. W. Tester, A. Porter, S. Asbell, C. Coughlin, J. Heaney, and J. Krall Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12 Int J Radiat Oncol Biol Phys 25 1993 783 790 (Pubitemid 23123381)
10. W. Tester, R. Caplan, J. Heaney, P. Venner, R. Whittington, and R. Byhardt Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 88-02 J Clin Oncol 14 1996 119 126 (Pubitemid 26020004)
11. D.S. Kaufman, K.A. Winter, and W.U. Shipley The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response Oncologist 5 2000 471 476
12. M.P. Hagan, K.A. Winter, D.S. Kaufman, Z. Wajsman, A.L. Zietman, and N.M. Heney RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy Int J Radiat Oncol Biol Phys 57 2003 665 672 (Pubitemid 37194292)
13. W.U. Shipley, K.A. Winter, D.S. Kaufman, W.R. Lee, N.M. Heney, and W.R. Tester Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03 J Clin Oncol 16 1998 3576 3583 (Pubitemid 28506771)
14. C.N. Sternberg, V. Pansadoro, F. Calabro, S. Schnetzer, D. Giannarelli, and P. Emiliozzi Can patient selection for bladder preservation be based on response to chemotherapy? Cancer 79 2003 1644 1652 (Pubitemid 36350708)
15. H.W. Herr Transurethral resection of muscle-invasive bladder cancer: 10-year outcome J Clin Oncol 19 2001 89 93 (Pubitemid 32063483)
16. C. Weiss, M. Wittlinger, D.G. Engehausen, F.S. Krause, O.J. Ott, and J. Dunst Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy Int J Radiat Oncol Biol Phys 70 2008 1502 1506 (Pubitemid 351417749)
17. A.L. Zietman, J. Grocela, E. Zehr, D.S. Kaufman, R.H. Young, and A.F. Althausen Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder Urology 58 2001 380 385 (Pubitemid 32816355)
18. B.H. Bochner, A.J. Figueroa, E.C. Skinner, G. Lieskovsky, Z. Petrovich, and S.D. Boyd Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure J Urol 160 1998 29 33 (Pubitemid 29479409)
19. M.K. Gospodarowicz, N.V. Hawkins, G.A. Rawlings, J.G. Connolly, M.A. Jewett, and G.M. Thomas Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis J Urol 142 1989 1448 1454 (Pubitemid 20011954)
20. P.W. Chung, R.G. Bristow, M.F. Milosevic, Q.L. Yi, M.A. Jewett, and P.R. Warde Long-term outcome of radiation-based conservation therapy for invasive bladder cancer Urol Oncol 25 2007 303 309 (Pubitemid 47031001)
21. S. Perdon, R. Autorino, R. Damiano, M. De Sio, B. Morrica, and L. Gallo Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience Cancer 112 2008 75 83
22. H. Mameghan, R. Fisher, J. Mameghan, and S. Brook Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder Int J Radiat Oncol Biol Phys 31 1995 247 254
23. M. Housset, B. Dufour, C. Maulard-Durdux, Y. Chretien, and A. Mejean Concomitant fluorouracil (5-fu)-cisplatin (cddp) and bifractionated split course radiation therapy (bscrt) for invasive bladder cancer Proc Am Soc Clin Oncol 15 1997 Abstract 1139
24. A. Chakravarti, K. Winter, C.L. Wu, D. Kaufman, E. Hammond, and M. Parliament Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group Int J Radiat Oncol Biol Phys 62 2005 309 317 (Pubitemid 40704444)
25. P. Lipponen, and M. Eskelinen Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis Br J Cancer 69 1994 1120 1125 (Pubitemid 24161872)
26. J.L. Wright, and M.P. Porter Quality-of-life assessment in patients with bladder cancer Nat Clin Pract Urol 4 2007 147 154 (Pubitemid 46416279)
27. M.S. Cookson The surgical management of muscle invasive bladder cancer: a contemporary review Semin Radiat Oncol 15 2005 10 18 (Pubitemid 40127274)
28. L. Henningsohn, H. Wijkström, P.W. Dickman, K. Bergmark, and G. Steineck Distressful symptoms after radical radiotherapy for urinary bladder cancer Radiother Oncol 62 2002 215 225 (Pubitemid 34286455)
29. A.L. Zietman, D. Sacco, U. Skowronski, P. Gomery, D.S. Kaufman, and J.A. Clark Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors J Urol 170 2003 1772 1776 (Pubitemid 37254925)
30. G. Dalbagni, E. Genega, M. Hashibe, Z.F. Zhang, P. Russo, and H. Herr Cystectomy for bladder cancer: a contemporary series J Urol 165 2001 1111 1116 (Pubitemid 32210214)